AN2 Therapeutics, Inc. (NASDAQ:ANTX) has 37 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Almitas Capital LLC | 31 Dec, 2025 | 1,479,129 | -1,377,517 | -48.22% | $1,686,207.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,080,070 | 0 | 0.00% | $1,231,280.00 |
| Pfizer Inc | 31 Dec, 2025 | 715,295 | 0 | 0.00% | $815,436.00 |
| Stonepine Capital Management, LLC | 31 Dec, 2025 | 627,668 | 63,755 | 11.31% | $715,542.00 |
| Peapod Lane Capital LLC | 31 Dec, 2025 | 593,396 | 4,180 | 0.71% | $676,471.00 |
| Bank Of Nova Scotia | 31 Dec, 2025 | 459,194 | 0 | 0.00% | $523,481.00 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 31 Dec, 2025 | 431,760 | -24,703 | -5.41% | $492,206.00 |
| Bank Of Montreal /Can/ | 31 Dec, 2025 | 422,077 | 0 | 0.00% | $481,168.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 385,312 | -385,308 | -50.00% | $439,256.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 338,600 | -46,997 | -12.19% | $386,004.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 323,335 | 2,424 | 0.76% | $368,602.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 264,900 | -3,000 | -1.12% | $301,986.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 251,875 | 2,524 | 1.01% | $287,199.00 |
| Morgan Stanley | 31 Dec, 2025 | 229,770 | 39,000 | 20.44% | $261,938.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 178,518 | -44,819 | -20.07% | $203,511.00 |
| Woodline Partners LP | 31 Dec, 2025 | 145,971 | 145,971 | 0.00% | $166,407.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 115,536 | 92,523 | 402.05% | $131,711.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 95,683 | 95,683 | 0.00% | $109,079.00 |
| State Street Corp | 31 Dec, 2025 | 87,002 | 0 | 0.00% | $99,182.00 |
| Rangeley Capital, LLC | 31 Dec, 2025 | 65,000 | 0 | 0.00% | $74,100.00 |